• Home
  • Upcoming Meetings
  • About FDA Scientific Advisory Committee Meetings
  • FDA Office of the Commissioner (OC)
  • FDA Center for Biologics Evaluation & Research (CBER)
  • FDA Center for Drug Evaluation & Research (CDER)
  • Other US Advisory Committees
  • News
  • SAC Tracker Meeting Reports
  • Other FDA Committees
  • Our Team
  • Contact us
Menu

SAC Tracker

19 Klerkegade
København, 1308
+45 72112124
Regulatory Intelligence for Scientific Advisory Committee Meetings

SAC Tracker

  • Home
  • Upcoming Meetings
  • Advisory Committees
    • About FDA Scientific Advisory Committee Meetings
    • FDA Office of the Commissioner (OC)
    • FDA Center for Biologics Evaluation & Research (CBER)
    • FDA Center for Drug Evaluation & Research (CDER)
    • Other US Advisory Committees
  • News
  • About
    • SAC Tracker Meeting Reports
    • Other FDA Committees
    • Our Team
    • Contact us

MAY 25 ODAC

May 23, 2017 jessica adams

Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Epoetin Hospira, a Proposed Biosimilar of Amgen’s Epogen by Hospira Report

In Briefing Summary Tags FDA, ODAC
← MAY 24 ODACMAY 24 ODAC →

Filter by Category

  • Meeting Announcement (97)
  • Briefing Summary (157)
  • Results Wire (175)
  • Background Analysis (214)

Filter by Tag

  • ADMAC (1)
  • AMAC (1)
  • Actavis (1)
  • Avedro (1)
  • BPCA (1)
  • BS (1)
  • Breo Ellipta (1)
  • CABP (1)
  • Cempra (1)
  • DPP4 inhibitor (1)
  • Dynavax (1)
  • EGFR antibody (1)
  • GLP-1 agonist (1)
  • Hepatitis B vaccine (1)
  • HyQvia (1)
  • Janssen Biotech (1)
  • KemPharm (1)
  • PDMSIA (1)
  • PREA (1)
  • Perdue (1)
  • Repros Therapeutics (1)
  • Spectrum (1)
  • TNF inhibitor (1)
  • anticholinergic (1)
  • anticoagulant (1)
  • apaziquone (1)
  • buprenorphine (1)
  • compounding (1)
  • daibetes (1)
  • dry powder inhalers (1)
  • dsrm (1)
  • enclomiphene (1)
  • ethics (1)
  • famesoid X receptor antagonist (1)
  • gene therapies (1)
  • immune deficiency disorders (1)
  • immunoglobulins (1)
  • insulin glargine (1)
  • insuline glargine (1)
  • interleukin-5 (1)
  • metered dose inhalers (1)
  • naloxone (1)
  • obesity (1)
  • opiods (1)
  • partial 5HT1-A agonist (1)
  • selective uric acid re-absoprtion inhibitor (1)
  • tiotropium (1)
  • ulcertative colitis (1)
  • Baxter (2)
  • COPD (2)
  • Chantix (2)
  • D-ribose (2)
  • FLUAD (2)
  • Forest (2)
  • Mycobacterium phlei Cell wall-Nucleic Acid (2)
  • NPS Pharma (2)
  • Natpara (2)
  • Organon USA (2)
  • Probuphine (2)
  • SSRI (2)
  • acetayl-L-carnitine (2)
  • aloe vera (2)
  • antifungal (2)
  • antiseptics (2)
  • boswellia (2)
  • bovine heparin (2)
  • chondroitin sulfate (2)
  • etanercept (2)
  • food allergies (2)
  • gout (2)
  • hemoglobinurea (2)
  • hypogonadism (2)
  • hypoparathyroidism (2)
  • plaque psoriasis (2)
  • plasma derviatives (2)
  • quinacrine hydrochloride (2)
  • respiratory allergies (2)
  • selective relaxant binding agent (2)
  • skin cancer (2)
  • sunscreen (2)
  • therapeutic proteins (2)
  • vCJD (2)
  • weight management (2)
  • ABT-414 (3)
  • AbbVie (3)
  • Ardea Biosciences (3)
  • BSE (3)
  • BioMarin Pharmaceutical (3)
  • Braeburn (3)
  • CFTR corrector (3)
  • Clarus (3)
  • Clovis (3)
  • EFGR antibody (3)
  • Egalet (3)
  • Eisai (3)
  • GIDAC (3)
  • Galderma (3)
  • Intercept (3)
  • Roche (3)
  • SGLT2 inhibitor (3)
  • Sprout Pharmaceuticals (3)
  • Telesta Therapeutics (3)
  • Titan (3)
  • acne (3)
  • adalimumab (3)
  • adapalene gel (3)
  • aeroallergen immunotherapy (3)
  • androgen (3)
  • anti-EGFR (3)
  • anti-interleukin-5 antibody (3)
  • antisense oligomer (3)
  • antiviral (3)
  • aspirin (3)
  • atopic dermatitis (3)
  • atypical hemolytic uremic syndrome (3)
  • bacterial infection (3)
  • bezlotoxumab (3)
  • central nervous system agent (3)
  • codeine (3)
  • corneal ectasia (3)
  • drisapersen (3)
  • empagliflozin (3)
  • eosinophilic asthma (3)
  • fluoroquinolone (3)
  • fluticasone furoate and vilanterol (3)
  • food allergy immunotherapy (3)
  • glucocortoid (3)
  • hypertension (3)
  • inflammation (3)
  • keratoconus (3)
  • lenvatinib (3)
  • lesinurad (3)
  • lixisenatide (3)
  • long-acting beta-2-agonist (3)
  • non small cell lung cancer (3)
  • obeticholic acid (3)
  • ophthalmic solution (3)
  • opioid dependence (3)
  • paroxysmal nocturnal hemoglobinurea (3)
  • pregnancy (3)
  • prevention of C.Diff infection recurrence (3)
  • primary biliary cholangitis (3)
  • reduce chin fat (3)
  • reslizumab (3)
  • riboflavin ophthalmic solutions with UV-A irradiation (3)
  • rociletinib (3)
  • secukinumab (3)
  • sedatives (3)
  • selective serotonin inverse agonist (3)
  • severe eosinophilic asthma (3)
  • statins (3)
  • tissue and gene therapy (3)
  • tyrosine-kinase inhibitor (3)
  • ulcerative colitis (3)
  • viral and bacterial gene therapies (3)
  • viral oncolytics (3)
  • vortioxetine (3)
  • 5HT1A and/or 5HT2A receptor antagonist (4)
  • ACPS-CP (4)
  • Acadia (4)
  • Alexion (4)
  • Astellas (4)
  • Cerexa (4)
  • Collegium Pharmaceuticals (4)
  • Daiichi Sankyo (4)
  • Fabre-Kramer (4)
  • Ferring (4)
  • Kytherea Biopharmaceuticals (4)
  • Nektar (4)
  • Parkinsons disease (4)
  • Pfizer (4)
  • Psoriasis (4)
  • RO5503781 (4)
  • Rockwell Medical (4)
  • Sandoz (4)
  • Synta (4)
  • TNF-alpha (4)
  • TSEAC (4)
  • The Medicines Company (4)
  • Valeant (4)
  • alirocumab (4)
  • alogliptin (4)
  • anesthetics (4)
  • bladder cancer (4)
  • brodalumab (4)
  • cancer (4)
  • cangrelor (4)
  • ceftazidime-avibactam (4)
  • cytolitic (4)
  • deoxycholic acid (4)
  • desmopressin (4)
  • ebola (4)
  • eculizumab (4)
  • edoxaban (4)
  • epidural steroid injections (4)
  • etirinotecan (4)
  • evolocumab (4)
  • exon-skipping therapy (4)
  • ezetimibe (4)
  • ferric pyrophosphate (4)
  • filgrastim (4)
  • flibanserin (4)
  • ganetespib (4)
  • gepirone (4)
  • hypoactive sexual desire disorder (4)
  • influenza vaccine (4)
  • insulin degludec (4)
  • invasive aspergillosis (4)
  • iron deficiency (4)
  • isavuconazole (4)
  • lumacaftor (4)
  • lung cancer (4)
  • melanoma (4)
  • mepolizumab (4)
  • mucormycosis (4)
  • multiple myeloma (4)
  • nebivolol (4)
  • necitumumab (4)
  • neutropenia (4)
  • nocturia (4)
  • oncolytics (4)
  • panobinostat (4)
  • pimavanserin (4)
  • psoriasis (4)
  • rheumatoid arthritis (4)
  • saxagliptin (4)
  • simvastatin (4)
  • talimogene laherparepvec (4)
  • valsartan (4)
  • Boehringer Ingelheim (5)
  • CLIAC (5)
  • CT-P13 (5)
  • Celltrion (5)
  • Crohn's disease (5)
  • Eli Lilly (5)
  • Purdue Pharma (5)
  • Sarepta Therapeutics (5)
  • ankylosing spondylitis (5)
  • anti-hypertensives (5)
  • asthma (5)
  • eteplirsen (5)
  • infliximab (5)
  • influenza (5)
  • psoriatic arthritis (5)
  • reversal of neuromuscular blockade (5)
  • sugammadex (5)
  • testosterone replacement therapy (5)
  • APAC (6)
  • AstraZeneca (6)
  • Cystic Fibrosis (6)
  • MIDAC (6)
  • Novo Nordisk (6)
  • Teva (6)
  • liraglutide (6)
  • monoclononal antibodies (6)
  • testosterone (6)
  • CFTR potentiator (7)
  • Duchenne muscular dystrophy (7)
  • GlaxoSmithKline (7)
  • Sanofi Aventis (7)
  • Takeda (7)
  • antibacterial (7)
  • major depressive disorder (7)
  • pediatric anesthesia (7)
  • Amgen (8)
  • PCSK9 inhibitor (8)
  • Vertex Pharmaceuticals (8)
  • high cholesterol (8)
  • ivacaftor (8)
  • infection (9)
  • pediatric (10)
  • Merck (11)
  • NDAC (11)
  • blood donation (11)
  • diabetes (11)
  • vaccines (11)
  • AIDAC (12)
  • ACHDNC (13)
  • DODAC (13)
  • Novartis (13)
  • PCNS (13)
  • SACHRP (14)
  • biosimilar (14)
  • CRDAC (15)
  • RCAC (15)
  • reduce CV risk (16)
  • HHS (17)
  • AMDAC (19)
  • pain (19)
  • PADAC (22)
  • AAC (24)
  • PDAC (26)
  • BRUDAC (27)
  • CTGTAC (27)
  • BPAC (29)
  • PCAC (31)
  • PEDAC (34)
  • opioid (35)
  • SBFDA (36)
  • EMDAC (43)
  • VRBPAC (46)
  • AADPAC (59)
  • ODAC (63)
  • DSRM (78)
  • FDA (594)
You must select a collection to display.
 
Bottom-Logo.png
 
 

Copyright © 2017 Tarius A/S. All rights reserved.